LOW RISK MYELODYSPLASTIC SYNDROMES

Clinical trials for LOW RISK MYELODYSPLASTIC SYNDROMES explained in plain language.

Never miss a new study

Get alerted when new LOW RISK MYELODYSPLASTIC SYNDROMES trials appear

Sign up with your email to follow new studies for LOW RISK MYELODYSPLASTIC SYNDROMES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for MDS patients Who've run out of options

Disease control Recruiting now

This early-stage trial is testing an experimental pill called R289 for people with lower-risk myelodysplastic syndromes (MDS), a bone marrow disorder that causes anemia and frequent blood transfusions. The study focuses on patients whose disease hasn't responded to or has stopped…

Matched conditions: LOW RISK MYELODYSPLASTIC SYNDROMES

Phase: PHASE1, PHASE2 • Sponsor: Rigel Pharmaceuticals • Aim: Disease control

Last updated Feb 27, 2026 15:18 UTC

LOW RISK MYELODYSPLASTIC SYNDROMES

Get alerted when new LOW RISK MYELODYSPLASTIC SYNDROMES trials appear

New hope for MDS patients Who've run out of options